Amarin (AMRN +3.7%) is very close to receiving a long-sought patent on its lead drug candidate,...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN +3.7%) is very close to receiving a long-sought patent on its lead drug candidate, AMR101, after the USPTO issues a Notice of Allowance supporting the use of the fish-oil heart pill in patients with high triglycerides. A Notice of Allowance is typically issued after regulators decide that a patent can be granted from an application. Next up is an FDA decision on AMR101, expected this month. (PR)